Stryker Corporation (SYK) EV/EBITDA Ratio: 21.49x
Is Stryker Corporation’s EV/EBITDA ratio high or low?
Stryker Corporation's EV/EBITDA ratio of 21.49x is 30% below its 5-year average of 30.62x, near the low end of its 5-year range (19.73x–43.38x).
As of Wednesday, June 17, 2026. 30.29% below its 12-month average of 30.83x.
SYK EV/EBITDA Ratio Chart
SYK Average EV/EBITDA Ratio Chart
SYK Current vs Average EV/EBITDA Ratio Chart
SYK EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
21.49x
EV/EBITDA RATIO AVG TTM
30.83x
EV/EBITDA RATIO AVG 3Y
30.96x
EV/EBITDA RATIO AVG 5Y
30.37x
EV/EBITDA RATIO AVG 10Y
27.90x
EV/EBITDA RATIO AVG 15Y
22.87x
EV/EBITDA RATIO AVG 20Y
20.17x
CURRENT VS TTM AVG
-30.29%
CURRENT VS 3Y AVG
-30.58%
CURRENT VS 5Y AVG
-29.24%
CURRENT VS 10Y AVG
-22.96%
CURRENT VS 15Y AVG
-6.04%
CURRENT VS 20Y AVG
+6.52%
SYK Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Stryker Corporation (SYK) | $119.06B | 21.49x | 30.83x | 30.96x | 30.37x |
| Bristol-Myers Squibb Company (BMY)vs › | $114.38B | 10.90x | 9.67x | 16.61x | 15.45x |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $113.82B | 20.77x | 22.82x | 82.27x | 54.94x |
| CVS Health Corporation (CVS)vs › | $127.54B | 17.75x | 14.98x | 11.88x | 12.01x |
| Danaher Corporation (DHR)vs › | $128.72B | 21.31x | 23.47x | 23.90x | 22.36x |
| Medtronic plc (MDT)vs › | $104.05B | 13.03x | 15.68x | 15.65x | 17.02x |
| Intuitive Surgical, Inc. (ISRG)vs › | $148.26B | 34.23x | 46.93x | 54.29x | 52.30x |
| Pfizer Inc. (PFE)vs › | $148.76B | 12.64x | 10.55x | 15.97x | 13.74x |
| HCA Healthcare, Inc. (HCA)vs › | $88.05B | 8.86x | 10.20x | 9.59x | 9.11x |
| Elevance Health Inc. (ELV)vs › | $86.74B | 12.42x | 10.07x | 11.31x | 12.22x |
EV/EBITDA vs. its own history
At 21.5, EV/EBITDA is in its normal range, sitting higher than 56% of its 20-year history.
20-year low
6.8
median
16.9
20-year high
43.4
Stryker Corporation EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Stryker Corporation EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for Stryker Corporation (SYK)?
- The EV/EBITDA ratio for SYK stock is 21.49x.
- Is Stryker Corporation's EV/EBITDA ratio high or low?
- Stryker Corporation's EV/EBITDA ratio of 21.49x is 30% below its 5-year average of 30.62x, near the low end of its 5-year range (19.73x–43.38x).
- What is the TTM average EV/EBITDA ratio for Stryker Corporation (SYK)?
- The TTM average EV/EBITDA ratio for SYK stock is 30.83x.
- What is the 3Y average EV/EBITDA ratio for Stryker Corporation (SYK)?
- The 3Y average EV/EBITDA ratio for SYK stock is 30.96x.
- What is the 5Y average EV/EBITDA ratio for Stryker Corporation (SYK)?
- The 5Y average EV/EBITDA ratio for SYK stock is 30.37x.
- What is the 10Y average EV/EBITDA ratio for Stryker Corporation (SYK)?
- The 10Y average EV/EBITDA ratio for SYK stock is 27.90x.
- What is the 15Y average EV/EBITDA ratio for Stryker Corporation (SYK)?
- The 15Y average EV/EBITDA ratio for SYK stock is 22.87x.
- What is the 20Y average EV/EBITDA ratio for Stryker Corporation (SYK)?
- The 20Y average EV/EBITDA ratio for SYK stock is 20.17x.
Stryker Corporation EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-06-16 | 21.49x |
| 2026-06-15 | 21.32x |
| 2026-06-12 | 21.59x |
| 2026-06-11 | 21.18x |
| 2026-06-10 | 21.38x |
| 2026-06-09 | 21.70x |
| 2026-06-08 | 20.92x |
| 2026-06-05 | 21.18x |
| 2026-06-04 | 20.90x |
| 2026-06-03 | 20.51x |
| 2026-06-02 | 20.40x |
| 2026-06-01 | 20.79x |
| 2026-05-29 | 21.14x |
| 2026-05-28 | 21.30x |
| 2026-05-27 | 21.19x |
| 2026-05-26 | 21.64x |
| 2026-05-22 | 21.86x |
| 2026-05-21 | 21.67x |
| 2026-05-20 | 22.17x |
| 2026-05-19 | 21.94x |
| 2026-05-18 | 21.65x |
| 2026-05-15 | 21.25x |
| 2026-05-14 | 21.17x |
| 2026-05-13 | 20.95x |
| 2026-05-12 | 20.47x |
| 2026-05-11 | 19.73x |
| 2026-05-08 | 20.79x |
| 2026-05-07 | 21.37x |
| 2026-05-06 | 21.24x |
| 2026-05-05 | 21.43x |
| 2026-05-04 | 21.15x |
| 2026-05-01 | 21.40x |
| 2026-04-30 | 22.74x |
| 2026-04-29 | 22.74x |
| 2026-04-28 | 23.15x |
| 2026-04-27 | 23.65x |
| 2026-04-24 | 23.55x |
| 2026-04-23 | 23.69x |
| 2026-04-22 | 23.67x |
| 2026-04-21 | 23.53x |
| 2026-04-20 | 24.26x |
| 2026-04-17 | 24.58x |
| 2026-04-16 | 24.26x |
| 2026-04-15 | 24.45x |
| 2026-04-14 | 24.75x |
| 2026-04-13 | 24.84x |
| 2026-04-10 | 24.31x |
| 2026-04-09 | 24.31x |
| 2026-04-08 | 24.37x |
| 2026-04-07 | 23.85x |
| 2026-04-06 | 23.86x |
| 2026-04-02 | 23.81x |
| 2026-04-01 | 23.67x |
| 2026-03-31 | 23.62x |
| 2026-03-30 | 23.46x |
| 2026-03-27 | 23.54x |
| 2026-03-26 | 23.88x |
| 2026-03-25 | 23.56x |
| 2026-03-24 | 23.61x |
| 2026-03-23 | 23.88x |
| 2026-03-20 | 24.08x |
| 2026-03-19 | 24.35x |
| 2026-03-18 | 24.75x |
| 2026-03-17 | 24.96x |
| 2026-03-16 | 24.99x |
| 2026-03-13 | 24.15x |
| 2026-03-12 | 24.18x |
| 2026-03-11 | 24.74x |
| 2026-03-10 | 25.59x |
| 2026-03-09 | 26.06x |
| 2026-03-06 | 25.97x |
| 2026-03-05 | 26.36x |
| 2026-03-04 | 27.11x |
| 2026-03-03 | 27.29x |
| 2026-03-02 | 27.45x |
| 2026-02-27 | 27.47x |
| 2026-02-26 | 27.38x |
| 2026-02-25 | 27.25x |
| 2026-02-24 | 27.07x |
| 2026-02-23 | 27.30x |
| 2026-02-20 | 27.00x |
| 2026-02-19 | 26.51x |
| 2026-02-18 | 26.81x |
| 2026-02-17 | 26.28x |
| 2026-02-13 | 26.07x |
| 2026-02-12 | 26.06x |
| 2026-02-11 | 25.92x |
| 2026-02-10 | 33.01x |
| 2026-02-09 | 32.59x |
| 2026-02-06 | 32.78x |
| 2026-02-05 | 33.12x |
| 2026-02-04 | 32.97x |
| 2026-02-03 | 32.99x |
| 2026-02-02 | 33.59x |
| 2026-01-30 | 33.71x |
| 2026-01-29 | 32.45x |
| 2026-01-28 | 32.74x |
| 2026-01-27 | 32.47x |
| 2026-01-26 | 32.67x |
| 2026-01-23 | 32.51x |
| 2026-01-22 | 32.81x |
| 2026-01-21 | 33.16x |
| 2026-01-20 | 32.89x |
| 2026-01-16 | 33.23x |
| 2026-01-15 | 33.13x |
| 2026-01-14 | 32.87x |
| 2026-01-13 | 32.57x |
| 2026-01-12 | 33.03x |
| 2026-01-09 | 33.54x |
| 2026-01-08 | 33.52x |
| 2026-01-07 | 33.56x |
| 2026-01-06 | 33.45x |
| 2026-01-05 | 31.99x |
| 2026-01-02 | 31.94x |
| 2025-12-31 | 32.21x |
| 2025-12-30 | 32.43x |
| 2025-12-29 | 32.30x |
| 2025-12-26 | 32.44x |
| 2025-12-24 | 32.48x |
| 2025-12-23 | 32.49x |
| 2025-12-22 | 32.63x |
| 2025-12-19 | 32.52x |
| 2025-12-18 | 32.35x |
| 2025-12-17 | 32.30x |
| 2025-12-16 | 32.23x |
| 2025-12-15 | 32.53x |
| 2025-12-12 | 32.43x |
| 2025-12-11 | 32.34x |
| 2025-12-10 | 32.40x |
| 2025-12-09 | 32.03x |
| 2025-12-08 | 32.39x |
| 2025-12-05 | 33.25x |
| 2025-12-04 | 33.28x |
| 2025-12-03 | 33.41x |
| 2025-12-02 | 33.47x |
| 2025-12-01 | 33.94x |
| 2025-11-28 | 33.85x |
| 2025-11-26 | 33.94x |
| 2025-11-25 | 34.17x |
| 2025-11-24 | 33.77x |
| 2025-11-21 | 33.60x |
| 2025-11-20 | 32.96x |
| 2025-11-19 | 33.27x |
| 2025-11-18 | 32.88x |
| 2025-11-17 | 32.93x |
| 2025-11-14 | 33.10x |
| 2025-11-13 | 34.03x |
| 2025-11-12 | 33.53x |
| 2025-11-11 | 33.23x |
| 2025-11-10 | 32.51x |
| 2025-11-07 | 32.59x |
| 2025-11-06 | 32.41x |
| 2025-11-05 | 32.73x |
| 2025-11-04 | 33.13x |
| 2025-11-03 | 32.77x |
| 2025-10-31 | 32.61x |
| 2025-10-30 | 34.13x |
| 2025-10-29 | 34.18x |
| 2025-10-28 | 34.71x |
| 2025-10-27 | 35.36x |
| 2025-10-24 | 35.20x |
| 2025-10-23 | 35.31x |
| 2025-10-22 | 35.75x |
| 2025-10-21 | 35.03x |
| 2025-10-20 | 35.15x |
| 2025-10-17 | 34.58x |
| 2025-10-16 | 34.15x |
| 2025-10-15 | 34.19x |
| 2025-10-14 | 34.21x |
| 2025-10-13 | 33.79x |
| 2025-10-10 | 33.76x |
| 2025-10-09 | 34.23x |
| 2025-10-08 | 34.66x |
| 2025-10-07 | 34.15x |
| 2025-10-06 | 33.90x |
| 2025-10-03 | 34.25x |
| 2025-10-02 | 33.91x |
| 2025-10-01 | 33.72x |
| 2025-09-30 | 34.19x |
| 2025-09-29 | 34.20x |
| 2025-09-26 | 34.13x |
| 2025-09-25 | 34.09x |
| 2025-09-24 | 34.32x |
| 2025-09-23 | 34.51x |
| 2025-09-22 | 34.90x |
| 2025-09-19 | 34.79x |
| 2025-09-18 | 34.87x |
| 2025-09-17 | 34.79x |
| 2025-09-16 | 34.77x |
| 2025-09-15 | 34.81x |
| 2025-09-12 | 35.33x |
| 2025-09-11 | 35.79x |
| 2025-09-10 | 35.30x |
| 2025-09-09 | 36.12x |
| 2025-09-08 | 36.15x |
| 2025-09-05 | 36.08x |
| 2025-09-04 | 36.25x |
| 2025-09-03 | 35.77x |
| 2025-09-02 | 35.88x |
| 2025-08-29 | 36.01x |
| 2025-08-28 | 35.86x |
| 2025-08-27 | 36.15x |
| 2025-08-26 | 36.25x |
| 2025-08-25 | 35.96x |
| 2025-08-22 | 36.24x |
| 2025-08-21 | 35.46x |
| 2025-08-20 | 36.05x |
| 2025-08-19 | 35.88x |
| 2025-08-18 | 35.19x |
| 2025-08-15 | 35.21x |
| 2025-08-14 | 34.93x |
| 2025-08-13 | 34.96x |
| 2025-08-12 | 34.77x |
| 2025-08-11 | 34.77x |
| 2025-08-08 | 34.85x |
| 2025-08-07 | 34.75x |
| 2025-08-06 | 34.63x |
| 2025-08-05 | 35.12x |
| 2025-08-04 | 35.18x |
| 2025-08-01 | 34.87x |
| 2025-07-31 | 37.95x |
| 2025-07-30 | 38.62x |
| 2025-07-29 | 38.64x |
| 2025-07-28 | 38.65x |
| 2025-07-25 | 38.90x |
| 2025-07-24 | 38.29x |
| 2025-07-23 | 38.67x |
| 2025-07-22 | 38.16x |
| 2025-07-21 | 37.47x |
| 2025-07-18 | 37.66x |
| 2025-07-17 | 37.61x |
| 2025-07-16 | 37.79x |
| 2025-07-15 | 37.76x |
| 2025-07-14 | 37.84x |
| 2025-07-11 | 37.66x |
| 2025-07-10 | 38.13x |
| 2025-07-09 | 37.89x |
| 2025-07-08 | 37.67x |
| 2025-07-07 | 37.93x |
| 2025-07-03 | 38.17x |
| 2025-07-02 | 37.87x |
| 2025-07-01 | 38.30x |
| 2025-06-30 | 38.20x |
| 2025-06-27 | 38.02x |
| 2025-06-26 | 37.74x |
| 2025-06-25 | 37.91x |
| 2025-06-24 | 37.40x |
| 2025-06-23 | 36.76x |
| 2025-06-20 | 36.44x |
| 2025-06-18 | 36.24x |
| 2025-06-17 | 36.25x |
| 2025-06-16 | 36.58x |
| 2025-06-13 | 36.59x |
| 2025-06-12 | 36.87x |
| 2025-06-11 | 36.92x |
| 2025-06-10 | 37.27x |
| 2025-06-09 | 37.03x |
| 2025-06-06 | 37.17x |
| 2025-06-05 | 37.10x |
| 2025-06-04 | 37.05x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Stryker Corporation
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Kevin A. Lobo